Loading
Loading…
New: tenders and results on WhatsApp
New: Find tenders, results and companies on WhatsApp, by text or voice note
New: tenders and results on WhatsApp
New: Find tenders, results and companies on WhatsApp, by text or voice note
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | sk life sciences | Awarded | 1 | ₹1,691.25 |
| 2 | Schedule 2 | MEDICAL EQUIPMENT AND ENGG COMPANY | Awarded | 1 | ₹1,926 |
| 3 | Schedule 3 | SUNIL PHARMACY | Awarded | 1 | ₹1,395 |
| 4 | Schedule 4 | sk life sciences | Awarded | 1 | ₹4,192.50 |
| 5 | Schedule 5 | MODERN MEDICAL HALL | Awarded | 1 | ₹5,220 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
28 Apr 2025, 7:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Neostigmine 0.5 mg 1 ml Inj
Succinylcholine Inj
Homatropine Hydrochloride Sol 2 percent
Ketorolac Tromethamine 0.4 percent Eye drops
Brimonidine Tartrate 0.2 percent Eye drops
Lignocaine Hyrochloride 4 percent topical solution bott of 30 ml
Sodium Chromoglycate eye drops 2 percent bott of 5 ml
Dorzolamide 2 per plus Timolol 0.5per bott of 5 ml
Tab Amisulpride 100 mg
Tab Zolpidem 10 mg
Tab Olanzapine 10 mg
Tab Haloperidol 5 mg
Haloperidol 5mg ml Inj
Vancomycin CP 500 mg Inj
Tab Doxepin 25 mg
Olopatadine Hydrochloride 0.1per Ophthalmic Soln bott of 5 ml
Moxifloxacin 0.5 percent Eye Ointment Pack of 5 gm
Tobramycin 0.3 percent bott of 5 ml
Atropine sulphate 1 percent w v bott of 3 ml
Tab Glibenclamide 5mg
Tab Gliclazide MR 30 mg
Povidone Iodine 200 mg Pessary
Tab Clomiphene Citrate 50 mg
7718173
GEM/2025/B/6120543
Two Packet Bid
Neostigmine 0.5 mg 1 ml Inj
15 days
Punjab; Amritsar
Item wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
₹3
50%
Exempted
29 Apr 2025
7 Apr 2025
28 Apr 2025
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | Neostigmine 0.5 mg 1 ml Inj | As Per Specifications (Pdf Attached) | 375 | Amp | AMRITSAR CITY | 15 |
| 2 | Succinylcholine Inj | As Per Specifications (Pdf Attached) | 90 | Amp | AMRITSAR CITY | 15 |
| 3 | Homatropine Hydrochloride Sol 2 percent | As Per Specifications (Pdf Attached) | 75 | Bott | AMRITSAR CITY | 15 |
| 4 | Ketorolac Tromethamine 0.4 percent Eye drops | As Per Specifications (Pdf Attached) | 390 | Bott | AMRITSAR CITY | 15 |
| 5 | Brimonidine Tartrate 0.2 percent Eye drops | As Per Specifications (Pdf Attached) | 450 | Bott | AMRITSAR CITY | 15 |
| 6 | Lignocaine Hyrochloride 4 percent topical solution bott of 30 ml | As Per Specifications (Pdf Attached) | 60 | Bott | AMRITSAR CITY | 15 |
| 7 | Sodium Chromoglycate eye drops 2 percent bott of 5 ml | As Per Specifications (Pdf Attached) | 150 | Bott | AMRITSAR CITY | 15 |
| 8 | Dorzolamide 2 per plus Timolol 0.5per bott of 5 ml | As Per Specifications (Pdf Attached) | 300 | Bott | AMRITSAR CITY | 15 |
| 9 | Tab Amisulpride 100 mg | As Per Specifications (Pdf Attached) | 300 | No | AMRITSAR CITY | 15 |
| 10 | Tab Zolpidem 10 mg | As Per Specifications (Pdf Attached) | 690 | No | AMRITSAR CITY | 15 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7718173.pdf
GEM_BID
d-222_2025-04-07-18-23-06_b9ed85532a8da2b1f9eb60d57c11e4b8.pdf
BOQ
d-218_2025-04-07-18-23-06_e9dc17ff5fc058bd2a9faee26d2dc3dc.csv
BOQ
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .